For specialists

The effectiveness of azithromycin in solving diagnostic issues at the outpatient stage of managing patients with bronchopulmonary pathology
Optimization of the treatment of chronic inflammatory diseases of the genital organs in women of fertile age, taking into account international experience
Microbiological aspects of dysbiosis in infertility and miscarriage of pregnancy and their correction
Management of patients with functional diarrhea
The effectiveness of combination therapy using meloxicam (Loxidol) and Cocarnit in the treatment of patients with chronic diseases of the musculoskeletal system during an exacerbation
Medotilin in the treatment of post-stroke cognitive impairment
Use of Medotilin and Elfunat in acute and subacute period of ischemic stroke
Cetirizine: constancy and variety of anti-allergic action
The efficacy and safety of ketorolac in arthroscopic anesthesia
Effect of Medotilin on the functional state of the brain in patients who have suffered acute cerebrovascular accidents of ischemic type

CARD-NOTIFICATION OF AN ADVERSE DRUG REACTION AND/OR LACK OF EFFICACY OF THE MEDICINE

INFORMATION ABOUT THE PATIENT

SUSPECTED AR/LE

Suspected AR (describe each clinical manifestation of the AR with dates and times of onset and end and outcome)/Indication of the LE

INFORMATION ABOUT SUSPECTED MEDICINES

INFORMATION ABOUT RELATED MEDICINES

(with the exception of drugs used to correct the effects of AR/LE)
(concomitant diagnoses, laboratory and instrumental studies, allergy history, pregnancy with gestational age, method of conception, pregnancy outcome (if the pregnancy ended, the date of delivery, type of delivery, etc.)

Information about the messenger

INFORMATION ABOUT THE MEDICAL/PHARMACY SPECIALIST

(if not the notifier)

MESSAGE CARD for the patient

to provide the patient and/or his/her representative with information on adverse drug reactions and/or lack of efficacy of the drug

INFORMATION ABOUT THE PATIENT

Information about the suspected medicine

Information on the prescription of the suspected medicinal product

Information about the messenger

Information about the physician, healthcare facility and place of residence of the patient who had an adverse medicine reaction and/or lack of efficacy of the medicine

розробка сайту Estetic web design